01/09/2026
A technology created in Puerto Rico is opening new opportunities to transform how clinical trial participants are identified and recruited.
I thank Enfoque Pymes de El Nuevo Día and journalist Sandra Torres for reviewing our business trajectory and sharing the vision behind Diversia Health.
Latinos represent about 20% of the U.S. population, but our participation in clinical trials continues to be significantly lower. At Diversia Health, we develop bilingual, culturally intelligent technology to identify, prequalify, and connect Hispanic and underrepresented communities with clinical research opportunities.
This article comes at a watershed moment: we are part of the 14th Generation of Parallel18, we have presented our vision at the U.S. Capitol, and we will soon be bringing our technology to the Society for Clinical Research Sites (SCRS) Global Site Solutions Summit in Orlando.
I also thank Yari Rivas and the entire Diversia Health team for their commitment and effort to achieve our goal of building a solution capable of impacting clinical research in the United States and Puerto Rico.
— Ángel Hoyos
CEO and co-founder of Diversia Health
Parallel18